ScholarIQanswers from OpenAlex & ORCID
Filip K. Knop
ResearcherPublications, citations & collaboration network
Filip K. Knop is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Filip K. Knop have?
ScholarIQindexed works
Filip K. Knop has 868 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Filip K. Knop have?
ScholarIQcitation count
Filip K. Knop has 29,184 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Filip K. Knop?
ScholarIQh-index
Filip K. Knop has an h-index of 91 in OpenAlex.
What is the i10-index of Filip K. Knop?
ScholarIQi10-index
Filip K. Knop has an i10-index of 388 in OpenAlex.
What is the ORCID of Filip K. Knop?
ScholarIQorcid
The ORCID for Filip K. Knop is on the source record.
What is the OpenAlex record for Filip K. Knop?
ScholarIQopenalex
The OpenAlex for Filip K. Knop is on the source record.
What are the most-cited papers on Filip K. Knop?
ScholarIQmost cited works
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Ruud S. Kootte, Evgeni Levin, Jarkko Salojärvi, Loek P. Smits, Annick V. Hartstra, S D Udayappan, Gerben D. A. Hermes, Kristien E. Bouter, Annefleur M. Koopen, Jens J. Holst, Filip K. Knop, Ellen E. Blaak, Jing Zhao, Hauke Smidt, Amy C. Harms, Thomas Hankemeijer, Jacques Bergman, Hans Romijn, Frank G. Schaap, Steven W.M. Olde Damink, Mariëtte T. Ackermans, Geesje M. Dallinga‐Thie, Erwin G. Zoetendal, Willem M. de Vos, Mireille J. Serlie, Erik S.G. Stroes, Albert K. Groen, Max Nieuwdorp
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Tina Vilsbøll, Mikkel Christensen, Anders Junker, Filip K. Knop, Lise Lotte Gluud
Recovery of gut microbiota of healthy adults following antibiotic exposure
Albert Pallejá, Stine Ulrik Mikkelsen, Sofia K. Forslund, Alireza Kashani, Kristine H. Allin, Trine Nielsen, Tue H. Hansen, Suisha Liang, Qiang Feng, Chenchen Zhang, Paul Theodor Pyl, Luís Pedro Coelho, Huanming Yang, Jian Wang, Athanasios Typas, Morten Frost Nielsen, Henrik Bjørn Nielsen, Peer Bork, Jun Wang, Tina Vilsbøll, Torben Hansen, Filip K. Knop, Manimozhiyan Arumugam, Oluf Pedersen
Glucagon-like peptide 1 in health and disease
Andreas Andersen, Asger Lund, Filip K. Knop, Tina Vilsbøll
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Filip K. Knop, Vanita R. Aroda, Ruben D do Vale, Thomas Holst‐Hansen, Peter Nørkjær Laursen, Julio Rosenstock, Domenica Rubino, W. Timothy Garvey